Cargando…
Alcoholic liver disease: A current molecular and clinical perspective()
Heavy alcohol use is the cause of alcoholic liver disease (ALD). The ALD spectrum ranges from alcoholic steatosis to steatohepatitis, fibrosis, and cirrhosis. In Western countries, approximately 50% of cirrhosis-related deaths are due to alcohol use. While alcoholic cirrhosis is no longer considered...
Autores principales: | Ohashi, Koichiro, Pimienta, Michael, Seki, Ekihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581514/ https://www.ncbi.nlm.nih.gov/pubmed/31214376 http://dx.doi.org/10.1016/j.livres.2018.11.002 |
Ejemplares similares
-
Intestinal Lipolysis Mitigates Nonalcoholic Fatty Liver Disease: New Roles for Carboxylesterase 2c in the Intestine
por: Pimienta, Michael, et al.
Publicado: (2019) -
Acrolein, a New Villain in the Development of Alcoholic Liver Disease
por: Seki, Ekihiro
Publicado: (2016) -
Tumor Suppressor Down-Regulation Promotes Hepatocyte Proliferation: A New GANKster on the Block
por: Pimienta, Michael, et al.
Publicado: (2018) -
TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis
por: Seki, Ekihiro
Publicado: (2014) -
Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets
por: Kim, Jieun, et al.
Publicado: (2023)